Correction:Phase 2 study of pembrolizumab in patients with advanced rare cancers

Authors :: Luc Dirix
Eyal Fenig
Rodrigo Munhoz
Elena Benincasa
Sarah Flaskett
Josh Reed
Arne Engelsberg
Source :: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020), Journal for Immunotherapy of Cancer
Publication Year :: 2020
Publisher :: BMJ, 2020.

Subjects :: Pharmacology
Cancer Research
Oncology
Immunology
Correction
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Molecular Medicine
Immunology and Allergy
RC254-282

Full Text Access

Tools